Getting to the Core: Should We Monitor Hepatitis B Core-Related Antigen?

Source: Addressing Misunderstandings in Applying HBV Treatment Guidelines
Hear expert insights on the potential role of the hepatitis B core-related antigen in monitoring patients for treatment candidacy and risk of hepatocellular carcinoma.
Yasuhito Tanaka, MD, PhD
Released: January 3, 2022 Expiration: No longer available for credit
Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from:
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings